Results 111 to 120 of about 156,340 (338)
AimsTo examine the long-term risk of hyperthyroidism in patients admitted to hospital with new-onset AF. Hyperthyroidism is a well-known risk factor for atrial fibrillation (AF), but it is unknown whether new-onset AF predicts later-occurring ...
Christian Selmer +12 more
doaj +1 more source
Predicting early risk of chronic kidney disease in cats using routine clinical laboratory tests and machine learning. [PDF]
BackgroundAdvanced machine learning methods combined with large sets of health screening data provide opportunities for diagnostic value in human and veterinary medicine.Hypothesis/objectivesTo derive a model to predict the risk of cats developing ...
Bradley, Richard +8 more
core +2 more sources
Cirrhosis is frequently accompanied by varying degrees of lipid profile abnormalities. This study confirms that these profiles are differentially affected by disease etiology and progressively worsen—with significant reductions in TC, HDL‐C, and LDL‐C—as liver disease severity increases. TIPS improves lipid profiles, particularly by increasing HDL‐C in
Jiamin Xu +6 more
wiley +1 more source
Chronic Kidney Disease in Cats and the Risk of Total Hypercalcemia [PDF]
BACKGROUND: Chronic kidney disease (CKD) is a common comorbidity in cats with hypercalcemia, but whether CKD is a risk factor for hypercalcemia is unclear.
Abdi +66 more
core +2 more sources
Ashwagandha: Is It Safe? Part 2: A Preclinical Evidence Review
ABSTRACT The preclinical evidence for the safety of ashwagandha (Withania somnifera (L.) Dunal, AS) is reviewed, and its preparations (extracts) and constituents, from the general toxicity in animal models to in vitro and cell culture studies, which may elucidate mechanisms of action and explain clinical case reports.
Elizabeth M. Williamson, Thomas Brendler
wiley +1 more source
BMQ: Boston Medical Quarterly was published from 1950-1966 by the Boston University School of Medicine and the Massachusetts Memorial ...
Antuna, Juan +25 more
core
Ashwagandha: Is It Safe? Part 1: A Regulatory Review
ABSTRACT Over the last decade, ashwagandha (Withania somnifera (L.) Dunal, AS) has been brought under increasing scrutiny by EU regulators regarding its safety for the use in food supplements, culminating in a recent recommendation for an Article 8 procedure according to Regulation (EC) No. 1925/2006 in the European Union (EU).
T. Brendler +5 more
wiley +1 more source
Evaluation of Potential Hormonal Activities of Ashwagandha (Withania somnifera)
ABSTRACT Ashwagandha is a widely used herb in traditional medicine systems, particularly Ayurveda. Despite its extensive tradition, growing concerns regarding its potential endocrinological effects have prompted scientific scrutiny. This review systematically evaluates the current preclinical, clinical, and case study evidence concerning AS's effects ...
Günter Vollmer, Thomas Brendler
wiley +1 more source
Iodination and its effect on hyperthyroidism
Background: Iodine supplementation with salt as a carrier was introduced in Sri Lanka in 1995. Literature from elsewhere suggest that there is an increase in hyperthyroidism after the initiation of such programmes.
P.C.A. Ratnatunga +6 more
doaj +1 more source
ABSTRACT Objective To investigate the influence of hearing loss on the efficacy of personalized and customized music therapy in patients with chronic tinnitus. Methods A total of 147 patients with chronic tinnitus were included in the research; according to the pure‐tone average (PTA) test results (PTA at 0.5, 1.0, 2.0, and 4.0 kHz), the patients were ...
Dan‐Dan Guo +8 more
wiley +1 more source

